Derivation of matrix *Q* in Equation (5) in Methods {#Sec1}
===================================================

Each site in the (diploid) genome can be in one of five states, 0/0, 0/-, 0/1, 1/-, or 1/1, where 0 denotes reference allele, 1 denotes variant allele, and - denotes a deletion.

We introduce two rate parameters: *λ*~*d*~: the rate of recurrent point mutation at a site.*λ*~*l*~: the combined rate of deletion and loss of heterozygosity (LOH).

Using these five states and rate parameters, we have the following instantaneous rate matrix *Q*:

We now abstract the genotypes as follows: Genotype 0 corresponds to states 0/- and 0/0.Genotype 1 corresponds to state 0/1.Genotype 2 corresponds to states 1/- and 1/1.

Under this abstraction and the assumptions detailed in the caption of Table [1](#Tab1){ref-type="table"}, we obtain the matrix *Q* given in Eq. (5) in the main text. Table 1Expanded *Q* matrix for ternary data0/-0/00/11/-1/10/-0NANANANA0/0*λ* ~*l*~-1 - *λ*~*l*~1NANA0/1$\documentclass[12pt]{minimal}
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                \begin{document}$\frac {\lambda _{d}}{2}$\end{document}$1/-NANANA0NA1/1NANA*λ* ~*d*~*λ* ~*l*~−*λ*~*l*~−*λ*~*d*~*Q*(*i*,*j*) denotes transition from state *i* to state *j*. The transitions for which the entry is 'NA', are not allowed. In particular, we do not allow the transitions 0/- → 1/- or 1/- →0/- as a reflection of a simplifying assumption that a recurrent point mutation and deletion/LOH occurring at the same site is a very rare event. Furthermore, we do not model copy number gain.

The following clarifications also apply to the main text: Given the explanation above, [the following statement should be removed]{.ul}: "LOH events can result in the genotype transitions 1→0 and 1→2 whereas deletions can result in the genotype transitions 1→0,1→2 or 2→1. To compute the infinitesimal rates for these transitions, we introduce two parameters *λ*~*d*~ and *λ*~*l*~ that account for the effects of deletion and LOH respectively."[The statement]{.ul}"It is important to note that out of the three different types of events that could hint at a deviation from the infinite-sites assumption, SiFit currently models events (deletions, LOH, etc.) that affect the same genomic site more than once and the FP and FN errors in SCS data."[should be replaced by]{.ul}"It is important to note that out of the three different types of events that could hint at a deviation from the infinite-sites assumption, SiFit currently models events (recurrent point mutations, deletions, LOH, etc.) that affect the same genomic site more than once and the FP and FN errors in SCS data."[The statement]{.ul}"These parameters being relative quantities (they denote the rates of deletion and LOH, respectively, relative to the rate of point mutations), we choose a beta distribution as their prior."[should be replaced by]{.ul}"These parameters being relative quantities (they denote the rates of recurrent point mutation and deletion/LOH, respectively, relative to the rate of point mutations), we choosea beta distribution as their prior."
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